Nicholas Husak, Alexander Sidlak, Rachael Westover, Stanislaw Haciski, Michael Abesamis
{"title":"Two fatalities from sodium azide ingestion: delayed enhanced elimination was not effective.","authors":"Nicholas Husak, Alexander Sidlak, Rachael Westover, Stanislaw Haciski, Michael Abesamis","doi":"10.1080/15563650.2025.2528995","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Ingestion of sodium azide can lead to severe toxicity, including the development of refractory shock. No antidote has been identified. Enhanced elimination has demonstrated variable outcomes in prior reports.</p><p><strong>Case reports: </strong>We present two fatal cases of sodium azide toxicity. The first patient, a 27-year-old man, ingested approximately 5 g of sodium azide and developed hypotension 1 h after ingestion. Orogastric lavage was performed, and vasopressors were started. Hemodialysis was performed 13 h after ingestion. Despite stabilization, he developed recurrent cardiac arrest and died. The second patient, a 19-year-old man, presented 2 h after the intentional ingestion of 40 mL of 5% (2 g) sodium azide. This patient was started on vasopressors and had plasma exchange performed, after which vasopressor requirements were reduced. Shortly after, however, the patient experienced recrudescence of shock and ultimately succumbed to toxicity.</p><p><strong>Discussion: </strong>Despite aggressive supportive measures, decompensation refractory to supportive measures occurred in both patients. Enhanced elimination techniques were attempted, albeit not immediately, and the delay in initiating hemodialysis and plasma exchange may have limited any potential benefit.</p><p><strong>Conclusions: </strong>Enhanced elimination did not appear to alter the course of toxicity in these two patients who ingested at least 2 g of sodium azide.</p>","PeriodicalId":520593,"journal":{"name":"Clinical toxicology (Philadelphia, Pa.)","volume":" ","pages":"681-683"},"PeriodicalIF":3.3000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical toxicology (Philadelphia, Pa.)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/15563650.2025.2528995","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/7/30 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Ingestion of sodium azide can lead to severe toxicity, including the development of refractory shock. No antidote has been identified. Enhanced elimination has demonstrated variable outcomes in prior reports.
Case reports: We present two fatal cases of sodium azide toxicity. The first patient, a 27-year-old man, ingested approximately 5 g of sodium azide and developed hypotension 1 h after ingestion. Orogastric lavage was performed, and vasopressors were started. Hemodialysis was performed 13 h after ingestion. Despite stabilization, he developed recurrent cardiac arrest and died. The second patient, a 19-year-old man, presented 2 h after the intentional ingestion of 40 mL of 5% (2 g) sodium azide. This patient was started on vasopressors and had plasma exchange performed, after which vasopressor requirements were reduced. Shortly after, however, the patient experienced recrudescence of shock and ultimately succumbed to toxicity.
Discussion: Despite aggressive supportive measures, decompensation refractory to supportive measures occurred in both patients. Enhanced elimination techniques were attempted, albeit not immediately, and the delay in initiating hemodialysis and plasma exchange may have limited any potential benefit.
Conclusions: Enhanced elimination did not appear to alter the course of toxicity in these two patients who ingested at least 2 g of sodium azide.
背景:摄入叠氮化钠可导致严重的毒性,包括难治性休克的发生。目前还没有找到解药。在以前的报告中,加强消除已显示出不同的结果。病例报告:我们提出两个致命的病例叠氮化钠中毒。第一位患者,一名27岁男性,摄入约5克叠氮化钠,并在摄入后1小时出现低血压。进行胃灌洗,并开始使用血管加压药。服药13 h后进行血液透析。尽管病情稳定,但他再次出现心脏骤停并死亡。第二例患者为一名19岁男性,在故意摄入40 mL 5% (2g)叠氮化钠2小时后出现。该患者开始使用血管加压素并进行血浆置换,之后血管加压素需求降低。然而,不久之后,患者经历了休克复发,最终死于毒性。讨论:尽管采取了积极的支持措施,但两例患者均出现了对支持措施难解的失代偿。虽然没有立即尝试增强消除技术,但延迟开始血液透析和血浆交换可能限制任何潜在的益处。结论:对于摄入至少2g叠氮化钠的两例患者,强化消除似乎并未改变毒性过程。